AIM ImmunoTech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.About AIM
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.
CEOThomas Kenwood Equels
CEOThomas Kenwood Equels
Employees23
Employees23
HeadquartersOcala, Florida
HeadquartersOcala, Florida
Founded1966
Founded1966
Employees23
Employees23
AIM Key Statistics
Market cap3.86M
Market cap3.86M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume272.82K
Average volume272.82K
High today$1.35
High today$1.35
Low today$1.26
Low today$1.26
Open price$1.26
Open price$1.26
Volume41.34K
Volume41.34K
52 Week high$35.96
52 Week high$35.96
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
With a market cap of 3.86M, AIM ImmunoTech(AIM) trades at $1.35. The stock has a price-to-earnings ratio of -0.07.
On 2026-01-09, AIM ImmunoTech(AIM) stock moved within a range of $1.26 to $1.35. With shares now at $1.35, the stock is trading +7.1% above its intraday low and 0.0% below the session's peak.
Trading volume for AIM ImmunoTech(AIM) stock has reached 41.34K, versus its average volume of 272.82K.
Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $35.96 and a low of $1.07.
Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $35.96 and a low of $1.07.
People also own
Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.